Chong Set Fui bought BGLC
August 13, 2026 · Form 4 insider transaction
Chong Set Fui bought 96,774 shares of BioNexus Gene Lab Corp., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
96,774
Price
N/A
Total value
N/A
InsiderChong Set Fui
Role—
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateAugust 13, 2026
Filing dateAugust 14, 2026
Shares owned after96,774
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a fully vested Other Stock-Based Award of 96,774 shares of common stock, no par value, granted on August 13, 2026 under the BioNexus Gene Lab Corp. 2025 Equity Incentive Plan. The award was granted for completed services, for no cash consideration and valued for Plan purposes at $1.55 per share (the Nasdaq closing price on August 12, 2026).